Hauser + THB: A new way to look at health benefits transparency.

Rx Patient Assistance Programs Revisited

matt-artz-pY_AZJfdbHQ-unsplash-540x330@2x
Private Equity Firms

Rx Patient Assistance Programs Revisited

Employers continue to spend a monumental amount of capital on specialty drugs for their workforce. In fact, specialty drugs were estimated to represent about 50 percent of total Rx spend in 2020, with inflation of about 23 percent from the year before. Despite these prescriptions accounting for a majority of overall spend, specialty drugs only accounted for 2% of total prescriptions filled. 

Optimizing 2022 Successes
January, 2022 – TBA
The past year has been one of learning, growing, and winning over clients with efficiency and transparency. Join us for a series of workshops where we learn from your peers’ successes and as we create repeatable formulas for optimizing these wins for future applications.

Luckily, there are a few ways to reduce the overall cost of specialty drugs. Patient assistance programs (PAP) are one of the top ways to achieve this. In this blog, we’ll cover this system in depth. 

What are Patient Assistance Programs?

Patience Assistance Programs are offered by select pharmaceutical companies, as well as certain state and non-profit entities. They are uniquely designed to lower the cost of expensive, yet vital drugs that improve the health of patients. Depending on the specific program and needs of the patient, these specialty drugs may potentially even be free.  

How Do They Work?

The benefits of these Patient Assistance Programs vary widely between programs. There are also varying requirements and enrollment processes for these programs differ as well. Once a patient finds that he or she qualifies for a specific PAP, the procedure for applying will be listed on the organization’s website. Alternatively, you can call or email them for more information.

That’s all you need to know about applying for patient assistance programs. While not all patients will apply for every program, those who require specialty drugs will undoubtedly find one for them. When considering reducing Rx spend, patient assistance programs should be a number one priority.